The Vanguard Group 13D and 13G filings for OnKure Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-01-31 09:56 am Purchase |
2024-12-31 | 13G | OnKure Therapeutics, Inc. OKUR |
The Vanguard Group | 706,733 5.580% |
706,733 (New Position) |
Filing |